According to The U.S. Minimally Invasive Aesthetics Market, a new industry report by Dymedex Consulting, distributed exclusively by Life Science Intelligence, the retail market for minimally invasive aesthetic procedures has a maximum realizable U.S. potential of just over $15 billion by 2016. As analyzed in the report, in order for this potential to be achieved, it will require a much broader engagement of suppliers and physicians to drive sustained growth. This surprising finding was determined by a rigorous analysis of the numbers of potential clients by age, income, and other factors, and their willingness to pay for these procedures, within the context of their discretionary incomes and alternatives.

Overall growth in this industry will largely be driven by the commitment of current clients to significantly increase their annual participation. The report details underlying market drivers and suggests potential strategies to achieve sustained growth. Both physicians and suppliers will need to significantly increase their marketing efforts for this to occur.

Major suppliers who participate in this market include: Allergan, Medicis, Q-Med, BioForm, Candela, Laserscope, Cutera, LUMENIS, Palomar, and ICN, among others.

Additional details on

this study are available at http://lifescienceintelligence.com/market-reports-page.php?id=DYM-0508 or by calling 714-847-3540 ext. 22.

About Life Science Intelligence (LSI)®

LSI delivers high-quality market data and information to medical technology executives, entrepreneurs, and investors. LSI produces the EMT (Emerging Medical Technologies)® Database, medtech market reports, and provides global custom research services, including market assessments and physician surveys. In addition, LSI partners with top-tier information companies such as Health Research International (HRI) and Windhover/Medtech Insight to distribute their high-end information products. www.LSintelligence.com

About Dymedex Consulting

Dymedex Consulting has established market development for medical technology as a powerful new business discipline. Our highly quantitative methods provide executives with critical new insights to help align resources and focus investments on previously unrecognized factors that drive adoption of medical technologies. www.dymedex.com